Skip to main content

Advertisement

SpringerLink
Log in

Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, van’t Wout JW, Verhoef G, Gerrits WB, van Dobbenburgh OA, Pasmans SG, Fijnheer R (2003) Cladribine therapy for systemic mastocytosis. Blood 102:4270–4276

    Article  CAS  PubMed  Google Scholar 

  2. Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, Longley BJ (2002) The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99:1741–1744

    Article  CAS  PubMed  Google Scholar 

  3. Pardanani A, Elliott M, Reeder T, Li CY, Baxter EJ, Cross NC, Tefferi A (2003) Imatinib for systemic mast-cell disease. Lancet 362:535–536

    Article  CAS  PubMed  Google Scholar 

  4. Pardanani A, Hoffbrand AV, Butterfield JH, Tefferi A (2004) Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine. Leuk Res 28:127–131

    Article  CAS  PubMed  Google Scholar 

  5. Tefferi A, Li CY, Butterfield JH, Hoagland HC (2001) Treatment of systemic mast-cell disease with cladribine. N Engl J Med 344:307–309

    Article  CAS  Google Scholar 

  6. Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122:695–717

    Article  PubMed  Google Scholar 

  7. World Health Organization Classification of Tumours. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haemopoietic and lymphoid tissues. IARC, Lyon, pp 291–302

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Oncology, and Transfusion Medicine, Charité-Campus Benjamin Franklin, Berlin, Germany

    Olaf Penack, Eckhard Thiel & Michael Notter

  2. Department of Pathology, University of Tübingen, Tübingen, Germany

    Karl Sotlar

  3. Department of Pathology, University of Lübeck, Lübeck, Germany

    Frank Noack & Hans-Peter Horny

Authors
  1. Olaf Penack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl Sotlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frank Noack
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hans-Peter Horny
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eckhard Thiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Notter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olaf Penack.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Penack, O., Sotlar, K., Noack, F. et al. Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia. Ann Hematol 84, 692–693 (2005). https://doi.org/10.1007/s00277-005-1057-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-1057-x

Keywords

Search

Navigation